Evolving Acquired Vemurafenib Resistance in a BRAF V600E Mutant Melanoma PDTX Model to Reveal New Potential Targets

József Tóvári(National Institute of Oncology), Mihály Cserepes(National Institute of Oncology)
Cells
July 24, 2023
Cited by 10


Related Papers